Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published online as doi:10.1189/jlb.1207835 on May 1, 2008

Published online before print May 1, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1207835v1
84/1/115    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Samten, B.
Right arrow Articles by Chroneos, Z. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Samten, B.
Right arrow Articles by Chroneos, Z. C.
(Journal of Leukocyte Biology. 2008;84:115-123.)
© 2008 by Society for Leukocyte Biology

An antibody against the surfactant protein A (SP-A)-binding domain of the SP-A receptor inhibits T cell-mediated immune responses to Mycobacterium tuberculosis

Buka Samten*,1, James C. Townsend*, Zvjezdana Sever-Chroneos{dagger}, Virginia Pasquinelli{ddagger}, Peter F. Barnes* and Zissis C. Chroneos{dagger}

* Department of Microbiology and Immunology and the Center for Pulmonary and Infectious Disease Control and
{dagger} Department of Biochemistry, the University of Texas Health Center, Tyler, Texas, USA; and
{ddagger} Department of Biological Chemistry, School of Sciences, University of Buenos Aires, Buenos Aires, Argentina

1Correspondence: Department of Microbiology and Immunology, the Center for Pulmonary and Infectious Disease Control, the University of Texas Health Center, 11937 U.S. Hwy. 271, Tyler, TX 75708, USA. E-mail: buka.samten{at}uthct.edu

ABSTRACT

Surfactant protein A (SP-A) suppresses lymphocyte proliferation and IL-2 secretion, in part, by binding to its receptor, SP-R210. However, the mechanisms underlying this effect are not well understood. Here, we studied the effect of antibodies against the SP-A-binding (neck) domain ({alpha}-SP-R210n) or nonbinding C-terminal domain ({alpha}-SP-R210ct) of SP-R210 on human peripheral blood T cell immune responses against Mycobacterium tuberculosis. We demonstrated that both antibodies bind to more than 90% of monocytes and 5–10% of CD3+ T cells in freshly isolated PBMC. Stimulation of PBMC from healthy tuberculin reactors [purified protein derivative-positive (PPD+)] with heat-killed M. tuberculosis induced increased antibody binding to CD3+ cells. Increased antibody binding suggested enhanced expression of SP-R210, and this was confirmed by Western blotting. The antibodies ({alpha}-SP-R210n) cross-linking the SP-R210 through the SP-A-binding domain markedly inhibited cell proliferation and IFN-{gamma} secretion by PBMC from PPD+ donors in response to heat-killed M. tuberculosis, whereas preimmune IgG and antibodies ({alpha}-SP-R210ct) cross-linking SP-R210 through the non-SP-A-binding, C-terminal domain had no effect. Anti-SP-R210n also decreased M. tuberculosis-induced production of TNF-{alpha} but increased production of IL-10. Inhibition of IFN-{gamma} production by {alpha}-SP-R210n was abrogated by the combination of neutralizing antibodies to IL-10 and TGF-β1. Together, these findings support the hypothesis that SP-A, via SP-R210, suppresses cell-mediated immunity against M. tuberculosis via a mechanism that up-regulates secretion of IL-10 and TGF-β1.

Key Words: cytokine • tuberculosis






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for Leukocyte Biology.